Research
Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3334 (Published 26 July 2017) Cite this as: BMJ 2017;358:j3334
Data supplement
Web Extra
- Data Supplement - Appendix: Supplementary materials
Related articles
- News Published: 03 April 2014; BMJ 348 doi:10.1136/bmj.g2579
- Research Published: 17 February 2016; BMJ 352 doi:10.1136/bmj.i637
- News Published: 07 February 2013; BMJ 346 doi:10.1136/bmj.f819
- Practice Published: 29 May 2008; BMJ 336 doi:10.1136/bmj.39527.628322.AD
- Head To Head Published: 09 July 2013; BMJ 347 doi:10.1136/bmj.f1880
- Letter Published: 24 October 2017; BMJ 359 doi:10.1136/bmj.j4866
- Research Published: 10 July 2019; BMJ 366 doi:10.1136/bmj.l4217
See more
- Introductory AddressProv Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1
- Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond'sProv Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10
- Mr. Warburton's Bill for the Regulation of the Medical ProfessionProv Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13
- An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive LetterpressProv Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4
- A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &cProv Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a
Cited by...
- Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies
- Sharing study materials in health and medical research
- Status, use and impact of sharing individual participant data from clinical trials: a scoping review
- Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
- The production of ignorance
- Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
- Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
- Commitments by the Biopharmaceutical Industry to Clinical Trial Transparency: The Evolving Environment
- Reflections on the history of systematic reviews
- Sackler Colloquium on Improving the Reproducibility of Scientific Research: Standards for design and measurement would make clinical research reproducible and usable
- Availability and Use of Shared Data From Cardiometabolic Clinical Trials
- Characteristics and publication fate of unregistered and retrospectively registered clinical trials submitted to The BMJ over 4 years